Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Gbi Biomanufacturing Appoints Jesse Mc Cool As Chief Executive Officer

PRIVATESep 10, 2026•about 1 hour ago

Position

Chief Executive Officer

Company

GBI BioManufacturing

Jesse McCool
PlantationManufacturingBiotechnology

Description

GBI Biomanufacturing announced the appointment of Jesse McCool, Ph.D., as Chief Executive Officer. Dr. McCool will lead GBI's transformation into a commercial-scale manufacturing partner while expanding the company's early-stage capabilities.

Company Information

Company

GBI BioManufacturing

Location

Plantation, Florida, United States

About

GBI is a uniquely qualified and flexible US–based CDMO (contract development and manufacturing organization) that offers a Single Source SolutionTM to enhance the value of complex biopharmaceuticals for our clients. With over 30 years of experience as an independent contract manufacturer, GBI has worked as a strategic partner with companies and medical institutions of all sizes, taking their products through clinical trials and towards rapid commercialization. GBI provides process development and cGMP manufacturing services encompassing drug substances and drug products for complex biologics, including multi-specific antibodies, recombinant proteins, antibody- conjugates, and other biologic products. For more information, please visit https://www.gbibio.com/ orContact: info@gbibio.com

Don't miss GBI BioManufacturing's next move

Get an email the moment GBI BioManufacturing changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
Muctarr
Senior decision-maker at this company
••••••••@••••••••

See Muctarr's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for GBI BioManufacturing's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

GBI BioManufacturing changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.